Burcu Isler

1.1k total citations
21 papers, 585 citations indexed

About

Burcu Isler is a scholar working on Epidemiology, Molecular Medicine and Applied Microbiology and Biotechnology. According to data from OpenAlex, Burcu Isler has authored 21 papers receiving a total of 585 indexed citations (citations by other indexed papers that have themselves been cited), including 8 papers in Epidemiology, 8 papers in Molecular Medicine and 7 papers in Applied Microbiology and Biotechnology. Recurrent topics in Burcu Isler's work include Antibiotic Resistance in Bacteria (8 papers), Antibiotic Use and Resistance (7 papers) and Antibiotics Pharmacokinetics and Efficacy (6 papers). Burcu Isler is often cited by papers focused on Antibiotic Resistance in Bacteria (8 papers), Antibiotic Use and Resistance (7 papers) and Antibiotics Pharmacokinetics and Efficacy (6 papers). Burcu Isler collaborates with scholars based in Australia, Türkiye and Singapore. Burcu Isler's co-authors include David L. Paterson, Yohei Doi, Robert A. Bonomo, Adam G. Stewart, Patrick N. A. Harris, Timothy J. Kidd, Abdullah Tarık Aslan, Murat Akova, Ozan İşler and Eamonn Ferguson and has published in prestigious journals such as Clinical Microbiology Reviews, Clinical Infectious Diseases and Antimicrobial Agents and Chemotherapy.

In The Last Decade

Burcu Isler

17 papers receiving 573 citations

Peers

Burcu Isler

ENDOC

EPIDE

PHARM

AMB

Shio-Shin Jean Taiwan

Lavinia Nery Villa Stangler Arend Brazil

F. Rossi Brazil

Yonggui Zheng China

Elsa De La Cadena Colombia

Eid Azar Lebanon

Panagiotis Poulikakos Greece

Branka Bedenić Croatia

Lauro Vieira Perdigão Neto Brazil

Thomas H. McConville United States

Shio-Shin Jean Taiwan

Burcu Isler

359 ×1.0

116 ×0.7

ENDOC

80 ×0.5

EPIDE

144 ×1.0

PHARM

136 ×1.1

AMB

Citations per year, relative to Burcu Isler Burcu Isler (= 1×) peers Shio-Shin Jean

Countries citing papers authored by Burcu Isler

Since Specialization

Citations

This map shows the geographic impact of Burcu Isler's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by Burcu Isler with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites Burcu Isler more than expected).

Fields of papers citing papers by Burcu Isler

Since Specialization

Physical SciencesHealth SciencesLife SciencesSocial Sciences

This network shows the impact of papers produced by Burcu Isler. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by Burcu Isler. The network helps show where Burcu Isler may publish in the future.

Co-authorship network of co-authors of Burcu Isler

This figure shows the co-authorship network connecting the top 25 collaborators of Burcu Isler. A scholar is included among the top collaborators of Burcu Isler based on the total number of citations received by their joint publications. Widths of edges represent the number of papers authors have co-authored together. Node borders signify the number of papers an author published with Burcu Isler. Burcu Isler is excluded from the visualization to improve readability, since they are connected to all nodes in the network.

All Works

Sort: Min cites: Since: Top N: Style:

20 of 20 papers shown

Horcajada, Juan Pablo, Ana Cristina Gales, Burcu Isler, et al.. (2025). Current and future options for the treatment of serious infections due to carbapenem-resistant Pseudomonas aeruginosa. Clinical Microbiology Reviews. 38(4). e0023324–e0023324.

Isler, Burcu, et al.. (2025). Advancing the management of prosthetic joint infections: a review of randomized controlled trials and emerging evidence. Antimicrobial Agents and Chemotherapy. 69(10). e0033825–e0033825.

Grillo, Sara, et al.. (2025). Does Biological Sex Determine the Natural History and Management of Infective Endocarditis?. Canadian Journal of Cardiology. 42(3). 559–574.

Horcajada, Juan Pablo, Ana Cristina Gales, Burcu Isler, et al.. (2025). How do I manage difficult-to-treat Pseudomonas aeruginosa infections? Key questions for today’s clinicians. Clinical Microbiology and Infection. 31(11). 1797–1806. 1 indexed citations

Hornuß, Daniel, Burcu Isler, Michele Bartoletti, et al.. (2025). Early oral switch therapy for infective endocarditis: An international cross-sectional survey on current use in clinical practice. FreiDok plus (Universitätsbibliothek Freiburg). 2(1). 105063–105063.

Stewart, Adam G., et al.. (2024). An Update on Recent Clinical Trial Data in Bloodstream Infection. Antibiotics. 13(11). 1035–1035. 1 indexed citations

Stewart, Adam G., et al.. (2023). Aspergillus Species Causing Invasive Fungal Disease in Queensland, Australia. Mycopathologia. 188(3). 211–219. 3 indexed citations

Isler, Burcu, Abdullah Tarık Aslan, David L. Paterson, et al.. (2023). Duration of antibiotic treatment and timing of oral switching for bloodstream infections: a survey on the practices of infectious diseases and intensive care physicians. International Journal of Antimicrobial Agents. 61(6). 106802–106802. 4 indexed citations

Stewart, Adam G., Burcu Isler, & David L. Paterson. (2022). An Australian perspective on antimicrobial stewardship programs and transplantation. Transplant Infectious Disease. 24(5). e13912–e13912. 2 indexed citations

10.

Holland, David J., Adam G. Stewart, Burcu Isler, et al.. (2022). Clinical prediction scores and the utility of time to blood culture positivity in stratifying the risk of infective endocarditis in Staphylococcus aureus bacteraemia. Journal of Antimicrobial Chemotherapy. 77(7). 2003–2010. 7 indexed citations

11.

Isler, Burcu, Abdullah Tarık Aslan, Murat Akova, Patrick N. A. Harris, & David L. Paterson. (2022). Treatment strategies for OXA-48-like and NDM producing Klebsiella pneumoniae infections. Expert Review of Anti-infective Therapy. 20(11). 1389–1400. 35 indexed citations

12.

İşler, Ozan, et al.. (2020). Limits of the social-benefit motive among high-risk patients: a field experiment on influenza vaccination behaviour. BMC Public Health. 20(1). 240–240. 27 indexed citations

13.

Paterson, David L., Burcu Isler, & Adam G. Stewart. (2020). New treatment options for multiresistant gram negatives. Current Opinion in Infectious Diseases. 33(2). 214–223. 32 indexed citations

14.

Isler, Burcu, Timothy J. Kidd, Adam G. Stewart, Patrick N. A. Harris, & David L. Paterson. (2020). Achromobacter Infections and Treatment Options. Antimicrobial Agents and Chemotherapy. 64(11). 117 indexed citations

15.

Isler, Burcu, Patrick N. A. Harris, Adam G. Stewart, & David L. Paterson. (2020). An update on cefepime and its future role in combination with novel β-lactamase inhibitors for MDR Enterobacterales and Pseudomonas aeruginosa. Journal of Antimicrobial Chemotherapy. 76(3). 550–560. 34 indexed citations

16.

Isler, Burcu, et al.. (2020). Is Ceftazidime/Avibactam an Option for Serious Infections Due to Extended-Spectrum-β-Lactamase- and AmpC-Producing Enterobacterales ?: a Systematic Review and Meta-analysis. Antimicrobial Agents and Chemotherapy. 65(1). 22 indexed citations

17.

Stewart, Adam G., Michael J. Satlin, Sanmarié Schlebusch, et al.. (2020). Completing the Picture—Capturing the Resistome in Antibiotic Clinical Trials. Clinical Infectious Diseases. 72(12). e1122–e1129. 2 indexed citations

18.

Isler, Burcu, Şiran Keske, Mustafa Aksoy, et al.. (2019). Antibiotic overconsumption and resistance in Turkey. Clinical Microbiology and Infection. 25(6). 651–653. 41 indexed citations

19.

Tekin, Süda, Şiran Keske, Ayşe Batırel, et al.. (2019). Predictors of fatality in influenza A virus subtype infections among inpatients in the 2015–2016 season. International Journal of Infectious Diseases. 81. 6–9. 27 indexed citations

20.

Isler, Burcu, Yohei Doi, Robert A. Bonomo, & David L. Paterson. (2018). New Treatment Options against Carbapenem-Resistant Acinetobacter baumannii Infections. Antimicrobial Agents and Chemotherapy. 63(1). 221 indexed citations

Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.

Explore authors with similar magnitude of impact